Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
Patent 6977089 Issued on December 20, 2005. Estimated Expiration Date: 
November 4, 2023. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 4, 2023. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPomegranate extracts and methods of using thereof Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans Patent #: 6641850 InventorsAssigneeApplicationNo. 10701918 filed on 11/04/2003US Classes:424/769, Containing or obtained from a tree having matured height of at least two meters424/776, Containing or obtained from a seed or nut424/777, Containing or obtained from a fruit (aka fructus), including berry514/824, ARTERIOSCLEROSIS424/744, Containing or obtained from Aloe (e.g., aloe vera, etc.)424/725PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)ExaminersPrimary: Tate, Christopher R.Attorney, Agent or FirmForeign Patent References
International ClassA61K035/78AbstractMethods of using pomegranate extracts of the present invention for treating patients with atherosclerosis, or increased intima-media thickness of an artery, are provided. The methods comprise the step of administering to the patient a composition comprising a therapeutically effective amount of an extract from pomegranate. The methods of the present invention may also be used to decrease the incidence of stroke or heart attack in a patient.Other References
| |
